Two phase 3 trials will study Kura Oncology’s ziftomenib for frontline acute myeloid leukemia, one with venetoclax and the ...

These studies represent promising new treatment options for chronic and progressive kidney diseases, offering renewed hope to ...

Covert operations, online takedowns, and multimillion-pound seizures – how regulators are tackling the criminal networks ...

A new opinion paper shows no convincing evidence that there is a causal link between gut bacteria and autism, citing weak ...

Older adults with apparent hypothyroidism may or may not need treatment. This second article about thyroid disease in older ...

Some primary care clinics are investing in social needs programs to overcome barriers to care. New evidence shows how these ...

Dr Mark Kris discusses how a small 2015 study with just two nivolumab doses led to a wave of curative-intent trials.

Ethicist Art Caplan discusses FDA layoffs and their impact on protection of human research subjects in clinical trials.

Medication overuse is a major preventable driver of headache-related disability across the globe, highlighting the need for ...

A systematic review reports that monoclonal antibodies and JAK inhibitors can be effective in the treatment and clearance of ...

Black or African American adults were diagnosed with diabetes 24% more frequently than the total population in 2024.

ACEI and ARB use in CKD has been available for over three decades, but it is still underutilized. Now, a new clinical ...